Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe
August 24 2022 - 7:00AM
Business Wire
Tom Flow Named Chief Operating Officer and
Steven George Named Commercial Director
International medical cannabis platform company Akanda Corp.
(“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that it
has appointed Tom Flow to the role of Chief Operating Officer of
Akanda and Managing Director of Holigen, and Steven George to the
role of Commercial Director, effective September 1, 2022. The
Company believes that these two hires will enhance its leadership
direction and boost profitability across the European medical
cannabis market.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220824005303/en/
The Company announced that it has
appointed Tom Flow to the role of Chief Operating Officer of Akanda
and Managing Director of Holigen. (Photo: Business Wire)
Mr. Flow is an accomplished global business leader with over 15
years of direct cannabis industry experience with an emphasis on
facility design and operations, including multiple large scale EU
GMP certified cultivation facilities. He is the co-founder of a
number of cannabis companies during this time, namely MedReleaf
Corp. which was subsequently sold to Aurora Cannabis (ACB-NASDAQ)
in a transaction valued at C$3.2 billion, The Flowr Corporation
(“Flowr”) (FLWR-TSXV) where he held executive roles including CEO,
COO, President and Managing Partner, and Holigen Limited which the
Company acquired from Flowr in May 2022.
Mr. George joins Akanda with extensive experience in the
financial services and cannabis sectors. After beginning his career
in business development roles within financial services, in 2017,
he moved to Portugal to obtain his MBA and started working in the
European cannabis industry the following year. In that time, he
served as both Iberian Country Manager and European Alliance
Manager at Tilray (TLRY-NASDAQ), where his accomplishments included
Tilray receiving the first ACM (marketing approval) for a cannabis
dried flower in Portugal during his tenure and managing the first
medical cannabis exports out of Portugal to Europe and Israel. In
July 2021, Mr. George left Tilray and started offering independent
advisory services to cannabis clients across the European
region.
“Adding proven and elite global cannabis executives like Tom and
Steven is an important milestone for Akanda, expanding our
capabilities and growing our leadership as we scale. This begins
with maximising our combined 10 metric tonne (22,000 lbs) annual
cultivation and processing capacity at our EU GMP certified indoor
premium cultivation facility in Sintra, Portugal. And, we will also
focus on commercially igniting our 180 acre GACP outdoor and
greenhouse site at Aljustrel, Portugal, which has over 100 metric
tonnes (220,000 lbs) of annual cultivation capacity,” said Tej
Virk, Chief Executive Officer at Akanda. “These hires are
illustrative of the ongoing work we’re doing to build the best team
possible to engage Europe’s rapidly growing cannabis market. Tom is
renowned for his operational prowess, having built and scaled
indoor premium cannabis cultivation businesses in both Canada and
Portugal. Steven, meanwhile, is a commercial pioneer in Europe and
will help us accelerate our path to profitability. We have the
in-house capability to take a leading position in the existing
European medical cannabis market, with an eye to participate in the
adult-use market when it opens up.”
Both Mr. Flow and Mr. George will be based in offices at
Akanda’s indoor premium cultivation facility in Sintra,
Portugal.
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. Akanda’s
portfolio includes Bophelo Bioscience & Wellness, a GACP
qualified cultivation campus in the Kingdom of Lesotho in Southern
Africa; Holigen, a Portugal-based cultivator, manufacturer and
distributor with a prized EU GMP certified indoor grow facility;
and CanMart, a UK-based fully licensed pharmaceutical importer and
distributor which supplies pharmacies and clinics within the UK.
The Company’s seed-to-patient supply chain also includes
partnerships with Cellen Life Sciences’ Leva Clinic, one of the
first fully digital pain clinics in the UK, and other leading
distributors of medical cannabis in Germany.
Connect with Akanda: Website | LinkedIn | Twitter |
Instagram
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220824005303/en/
Investor Matt Chesler, CFA FNK IR ir@akandacorp.com
Media Imogen Saunders Irvine Partners
imogen@irvinepartners.co.uk
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Apr 2024 to May 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From May 2023 to May 2024